O’Melveny has advised Samsung Biologics. Samsung Biologics has signed a definitive agreement to acquire 100% of Human Genome Sciences from GSK for a total purchase price...
O’Melveny has advised Samsung Biologics. Samsung Biologics has signed a definitive agreement to acquire 100% of Human Genome Sciences from GSK for a total purchase price...
